The Peptide NewsroomPeptide research, industry and supply-chain headlines

NAD+ Skincare Goes Mainstream, But the Evidence Behind It Is a Shopping Page

Photograph: Beauty Skincare
Photo: "Beauty Skincare" by Authentic Stock is marked with CC0 1.0. Source: https://stocksnap.io/photo/beauty-skincare-CC9TYE8VJY

A shopping feature published by E Online reports that NAD+ has become the latest buzzed-about skincare ingredient, with several brands launching serums, creams and essences built around it. Activewear brand Alo recently launched NAD+ eye patches, which the brand says support the skin's moisture barrier.

NAD+ is short for nicotinamide adenine dinucleotide, and E Online notes that readers may recognize the term from celebrities receiving IV infusions containing the ingredient. The ingredient has now moved from infusions into topical skincare, according to the feature.

What the ingredient is supposed to do

Experts referenced in the piece say NAD+ is touted for cellular repair, reducing inflammation and firming skin, among other anti-aging benefits. The framing is the familiar one: like collagen, NAD+ levels decline as a person ages, which the outlet says is why the industry is exploring how those levels can be replenished.

What is actually on the shelf

The roundup names Numbuzin No.9 NAD+ BIO Lifting-Sil Essence, which E Online says combines NAD+ with peptides, alongside Medicube NAD+ EGF Firming Serum and Arencia NAD+ Booster Shot Cream. Alo Bio NAD+ Recovery Eye Masks are listed at $55, with the outlet noting that pricing and availability were accurate as of publication.

The peptides sitting next to it

Peptide products appear in the same roundup, including a copper peptide and bakuchiol serum that the outlet says promises to help improve fine lines, support elasticity and replenish moisture. Those are product claims, and no published studies are cited behind them.

Limitations

This is a shopping roundup, not a review of clinical evidence, and it names no published trial, sample size or measured result for NAD+ applied to skin. The experts it refers to are not named or quoted directly, and E Online says its editors select products based on research, reporting and reader interest.

Bottom line

The feature predicts it is only a matter of time until NAD+ is everywhere in skincare, and on current momentum that looks like a safe call. The unsettled part is the part that matters: with the claims attributed to brands and to unnamed experts, what topical NAD+ has been shown to do is still an open question, and a launch calendar is not an answer to it.

Source: RSS.app — Renewal bundle. Read the original.

Filed under: skin-beauty

Comments (0)

Discussion happens on Reddit.
Questions and corrections go to r/PeptideNewsroom.

Go to r/PeptideNewsroom

Corrections are the most useful thing you can post. Comments touching dosing, sourcing or links are held for a moderator first.

More from The Peptide Newsroom

Neuvera Launches Peptide G63 Skincare Bundle, But the Cited Trial Tested Another Formula

Neuvera has launched a two-step moisturizer bundle built on its patented Peptide G63 technology, citing a 2025 randomized trial in 60 women aged 60 to 90. That trial tested a different topical peptide formulation, not Neuvera's products.

Telangana Regulator Warns Online Peptide Buyers Risk Contamination, Serious Reactions and Death

Telangana's drug regulator TG SAFE has warned against buying or self-administering unapproved weight-loss drugs and experimental peptides sold on Telegram and other online platforms, naming BPC-157, GHK-Cu, retatrutide and tesamorelin. The advisory says such products may be contaminated, mislabelled or untested for sterility, and directs doctors not to prescribe them.

GHK-Cu Is One of Skincare's Most Studied Peptides, But Research Material Isn't a Product

A FindArticles roundup collects six recurring points about GHK-Cu, the copper tripeptide widely studied in a skin context. Its sharpest argument is that raw research material and a tested consumer cosmetic are not the same thing.